Search information
Abivax SA American Depositary Shares
Companies
"Employee"
Keywords
Tables in SEC filings
Source
(amounts in thousands of euros) | TAX AND EMPLOYEE-RELATED PAYABLES | AS OF DECEMBER 31, 2021 | AS OF DECEMBER 31, 2022 | AS OF DECEMBER 31, 2023 |
Employee-related payables | 1,180 | 1,348 | 3,694 | |
Social security and other | 777 | 840 | 2,251 | |
Other tax and related payments | 243 | 112 | 127 | |
Tax and employee-related payables | 2,200 | 2,300 | 6,073 |
(Amounts in thousands of euros) | Notes | AS OF DECEMBER 31, 2021 | AS OF DECEMBER 31, 2022 | AS OF DECEMBER 31, 2023 | ||
ASSETS | Non-current assets | Goodwill | 6 | 32,005 | 18,419 | 18,419 |
Intangible assets | 7 | 93 | 6,607 | 6,604 | ||
Property, plant and equipment | 8 | 305 | 1,592 | 878 | ||
Other financial assets | 9 | 1,342 | 11,708 | 12,870 | ||
Other assets | 10 | — | 1,037 | 2,320 | ||
Total non-current assets | 33,745 | 39,363 | 41,090 | |||
Current assets | Other financial assets | 9 | — | — | 9,186 | |
Other receivables and assets | 10 | 14,784 | 9,231 | 24,845 | ||
Cash and cash equivalents | 11 | 60,701 | 26,950 | 251,942 | ||
Total current assets | 75,485 | 36,181 | 285,972 | |||
TOTAL ASSETS | 109,230 | 75,544 | 327,062 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | Shareholders’ equity | Share capital | 168 | 223 | 629 | |
Premiums related to share capital | 107,578 | 150,476 | 478,218 | |||
Reserves | — | — | 112 | |||
Retained earnings | (39,361) | (82,770) | (135,209) | |||
Net loss for the period | (42,452) | (60,740) | (147,740) | |||
Total shareholders’ equity | 13 | 25,934 | 7,189 | 196,010 | ||
Non-current liabilities | Retirement benefit obligations | 16 | 693 | 610 | 629 | |
Provisions | 98 | 40 | 30 | |||
Borrowings | 15 | 16,458 | 9,127 | 2,563 | ||
Convertible loan notes | 15 | 18,191 | 19,332 | 42,295 | ||
Derivative instruments | 15 | 9,932 | 566 | — | ||
Royalty certificates | 15 | — | 3,287 | 12,229 | ||
Other financial liabilities | 15 | 5,659 | 3,262 | 3,262 | ||
Total non-current liabilities | 51,032 | 36,223 | 61,008 | |||
Current liabilities | Borrowings | 15 | 9,608 | 10,077 | 1,655 | |
Convertible loan notes | 15 | 625 | 625 | 8,952 | ||
Derivative instruments | 15 | — | — | 2,579 | ||
Other financial liabilities | 15 | 1,112 | 3,521 | 3,509 | ||
Trade payables and other current liabilities | 17.1 | 18,558 | 15,475 | 47,221 | ||
Tax and employee-related payables | 17.2 | 2,200 | 2,300 | 6,073 | ||
Deferred income | 162 | 133 | 52 | |||
Total current liabilities | 32,265 | 32,132 | 70,042 | |||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 109,230 | 75,544 | 327,062 |
ACTUARIAL ASSUMPTIONS | YEAR ENDED DECEMBER 31, 2021 | YEAR ENDED DECEMBER 31, 2022 | YEAR ENDED DECEMBER 31, 2023 |
Retirement age | 65 years for key management / 63 years for other employees | 65 years for key management / 63 years for other employees | 65 years for key management / 64 years for other employees |
Collective agreement | Pharmaceutical industry | Pharmaceutical industry | Pharmaceutical industry |
Discount Rate (IBoxx Corporates AA) | 0.90% | 3.65% | 3.34% |
Mortality rate table | INSEE 2016-2018 | INSEE 2016-2018 | INSEE 2016-2018 |
Salary increase rate | 3.00% for key management / 2.55% for other employees | 3.00% for key management / 2.55% for other employees | 3.00% |
Turnover rate | Decreasing from 5.80% at 20 years-old to 0.05% from 55 years-old | Decreasing from 5.80% at 20 years-old to 0.05% from 55 years-old | Decreasing from 5.80% at 20 years-old to 0.05% from 55 years-old |
Employee contribution rate | 45% | 45% | 45% |